Lars E. A. Haugom, MD, general practitioner.
PhD-candidate at Department of Global Public Health and Primary Care, University of Bergen (UiB), Norway
Web of Science ResearcherID: LUY-4620-2024
ORCiD: 0000-0001-7609-1082
Bluesky: @lars-haugom.bsky.social
Twitter/X: @LarsHaugom
The COVID-19 pandemic introduced an unprecedented and enduring increase in the use of remote consultations in Norwegian primary care with unknown implications for the antibiotic treatment of urinary tract infections (UTIs).
This PhD-project will provide new knowledge about how the COVID-19 pandemic affected health care seeking behavior, antibiotic use and clinical outcomes of UTIs.
We have planned three studies, investigating:
Consultations for and antibiotic treatment of UTI before the COVID-19 pandemic.
Risk of pyelonephritis and hospital admitted pyelonephritis when using remote consultations for acute cystitis.
Financing provided by:
A.The Norwegian Research Fund for General Practice (AMFF), Norwegian Medical Association, stipend, 50%
B. Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM), grant.
Main supervisor: Knut Eirik Ringheim Eliassen, Associate Professor
Assisting supervisors: Knut Erik Emberland, Associate Professor & Ingrid Keilegavlen Rebnord, Associate Professor
Department of Global Public Health and Primary Care, University of Bergen, Norway
Risk of pyelonephritis following remote consultations for cystitis, a retrospective cohort study*
*Tentative title
Consultations and antibiotic treatment for urinary tract infections in Norwegian primary care 2006–2015, a registry-based study
Findings include a marked increase year-by-year in the proportion of physical consultations resulting in antibiotic treatment.
Presenting findings from the first study.
Remote vs. in-person consultations for acute cystitis during the COVID-19 pandemic; antibiotic treatment and clinical outcomes, a retrospective cohort study
Findings not yet published
Pictured above, participation at GRIN 2024. Lars Haugom first row in green shirt.
Midway evaluation at the University of Bergen.